ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Wendy Will Case Found Invites Applications For Small Grants

April 5, 1991

Foundation Gives $1 Million To UPCI For Genetics Chair

December 13, 2002

NCI-Approved Protocols Listed

March 28, 2003

Cancer Advocacy: Survivors, Supporters Gather to Light Candles, Curse the Darkness

October 1, 1999

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

May 8, 1981

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991